TWST

#1255
Twist Bioscience Corporation - Common Stock
66.8 7 USD
-3.13%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
66.87
66.87
년간 변동
23.30
69.20
일일 변동
-3.13%
월간 변동
+16.30%
6달 변화
+114.05%
년간 변동율
+133.73%
이전 종가
69.0 3
Open
66.8 7
저가
66.8 7
High
66.8 7
양
165
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
  • Market Capitalization 4.16 B
  • Employee 979
  • Founded 2013
  • CEO Emily LeProust
  • Website www.twistbioscience.com
  • Headquarter Delaware, United States
  • FIGI BBG006KDCHJ4
  • Industry 분석 & 리서치
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-21.65
주가매출액비율
4.47

Twist Bioscience Corporation - Common Stock

Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck. The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox. In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes.

뉴스